Company Focus

CellTrion

Latest CellTrion News

Added FDA approval for Celltrion’s Yuflyma
Biosimilars
The Food and Drug Administration (FDA) has granted an expanded interchangeable designation for Yuflyma (adalimumab-aaty), now including prefilled syringe (40mg) and autoinjectors (40mg and 80mg) presentations.   26 May 2025


Latest News & Features of interest to CellTrion

Latest Relevant Ones To Watch News

US CAR-T focused biotech CARGO Therapeutics today announced that it has entered into a definitive merger agreement with Concentra Biosciences, initially worth roughly $200 million. The news sent CARGO’s stock up as much as 9.6% to $4.81 in pre-market activity.   8 July 2025

More in M&A >


Relevant Ones to Watch Companies

Reset all filters
Refine Search